The UK’s competition watchdog fined New York-based Pfizer £63m and imposed a £6.7m penalty on Flynn, a smaller UK pharmaceutical firm based in Stevenage. Both companies said they would appeal. The Guardian
Friday, 22 July 2022
Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug
Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug The drug makers Pfizer and Flynn Pharma have been fined a total of £70m for overcharging the NHS for a life-saving epilepsy drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment